Exploring Key Insights of the Congestive Heart Failure (CHF) Market: Growth Prospects, Emerging Trends, and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the congestive heart failure (chf) market grown over the years?
The market for congestive heart failure (CHF) has witnessed a robust expansion in the past few years. It is projected to elevate from $15.94 billion in 2024 to $17.10 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.2%. The substantial growth during the historical period is primarily owing to the high incidence of aging population, expansion in cardiovascular diseases, increased cognizance about heart health, amplified healthcare spending, and escalating demand for remote patient surveillance.
What Is the forecasted market size and growth rate for the congestive heart failure (chf) market?
The market size of congestive heart failure (CHF) is projected to witness significant expansion in the coming years, scaling up to $22.31 billion by 2029 with a compound annual growth rate (CAGR) of 6.9%. The growth forecast for the period can be credited to several factors such as the escalating adoption of digital health solutions, a growing incidence of hypertension, increasing obesity indexes, enhancements in patient results, and a heightened emphasis on personalized medicine. Key trends projected to mark the forecast period include improvements in diagnostic technologies, progress in treatment alternatives, technological evolution in imaging, breakthroughs in therapeutic strategies, and advancements in wearable health technology.
Get your congestive heart failure (chf) market report here!
https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-chf-global-market-report
What are the major factors driving growth in the congestive heart failure (chf) market?
The surge in cardiovascular patients is anticipated to drive the expansion of the congestive heart failure (CHF) market in future. Cardiovascular entails the heart and blood vessels and their pivotal role in blood circulation and overall health maintenance. Unhealthy dietary choices, sedentary living habits, ageing population and urban sprawl contribute to escalating cardiovascular patients, necessitating advanced healthcare and treatment options. Congestive heart failure (CHF) offers specific solutions for cardiovascular patients, enhancing heart effectiveness, decreasing symptoms, preventing complications, and ultimately improving the quality of patient care and well-being. For example, the American College of Cardiology, a U.S. nonprofit medical organization, reported in January 2023 that cardiovascular disease cases escalated to 19.8 million in 2022. Additionally, Eastern Europe registers the highest mortality rate with 553 deaths per 100,000. Thus, the surge in cardiovascular patients is fueling the growth of the congestive heart failure (CHF) market.
What key areas define the segmentation of the global congestive heart failure (chf) Market?
The congestive heart failure (CHF) market covered in this report is segmented –
1) By Type: Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure
2) By Treatment: Medication, Surgery
3) By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings
Subsegments:
1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF), Mild-to-moderate Reduced Ejection Fraction
2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF), Borderline Ejection Fraction (HFpEF)
3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure, Chronic Left-Sided Heart Failure
4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure, Chronic Right-Sided Heart Failure
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20730&type=smp
What are the top market players propelling the growth of the congestive heart failure (chf) industry?
Major companies operating in the congestive heart failure (CHF) market are Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova
What are the key trends shaping the future of the congestive heart failure (chf) market?
Major companies operating in the congestive heart failure (CHF) market are focusing on advanced innovations, such as single intracoronary infusion therapies to offer effective treatment options that improve heart function and enhance the quality of life for CHF patients. Single intracoronary infusion delivers medication directly into the coronary artery, targeting the heart to provide precise treatment for conditions like congestive heart failure (CHF). For instance, in January 2024, Bayer AG, a Germany-based pharmaceutics company, and Asklepios Biopharmaceutical, Inc., a US-based biotechnology company, initiated the GenePHIT Phase II trial for AB-1002, an investigational gene therapy for congestive heart failure (CHF). This innovation utilizes a gene therapy approach to target non-ischemic cardiomyopathy, offering a potential breakthrough in the treatment of CHF through advanced genetic solutions. The trial is adaptive, double-blind, placebo-controlled, and will enroll between 90 and 150 participants who have been medically stable for at least four weeks and have a left ventricular ejection fraction between 15% and 35%.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20730
What regions are dominating the congestive heart failure (chf) market growth?
North America was the largest region in the congestive heart failure (CHF) market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure (CHF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Heating, Ventilation, And Air Conditioning Equipment Global Market Report 2025
Heart Attack Diagnostic Global Market Report 2025
https://thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report
Implantable Heart Pacemaker Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
